ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.4285
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,345.38
0.57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Penumbra Inc (PEN)

  7. Penumbra Inc (PEN) Noticias

Penumbra Inc

Penumbra Inc (PEN)

Peninsula Energy Ltd
Pennant International Group Plc
PBF Energy Inc
244.84
4.35
(1.81%)
Cerrado 24 Noviembre 3:00PM
Delayed by 15 minutes
244.84
0.00
(0.00%)
Fuera de horario: 6:26PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

PEN Noticias

Solo noticias oficiales

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 Octubre 2024
PEN (1.81%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
02 Octubre 2024
PEN (1.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Septiembre 2024
PEN (1.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 Septiembre 2024
PEN (1.81%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 Septiembre 2024
PEN (1.81%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 Septiembre 2024
PEN (1.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 Agosto 2024
PEN (1.81%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
22 Agosto 2024
PEN (1.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 Agosto 2024
PEN (1.81%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Agosto 2024
PEN (1.81%)

PEN Discussion

Ver más
@LaughinPaulRyan @LaughinPaulRyan 4 años hace
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 años hace
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 años hace
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 años hace
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 años hace
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 años hace
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 años hace
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 años hace
IPO should be out soon.
no symbol yet.
👍️0

Su Consulta Reciente

NYSE
PEN
Penumbra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados